Sign Up to like & get
recommendations!
1
Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.339
Abstract: Introduction and Objectives Letermovir (LTV) is the first agent in the class of anti-CMV viral terminase inhibitors and was recently approved in the U.S. for the prevention of CMV infection in CMV-seropositive allo-HCT recipients. In…
read more here.
Keywords:
allo hct;
cmv seropositive;
hct recipients;
cmv ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "EBioMedicine"
DOI: 10.1016/j.ebiom.2022.103887
Abstract: eBioMedicine 2022;77: 103887 Published online xxx https://doi.org/10.1016/j. ebiom.2022.103887 There is a widespread general consensus that protective immunity against infectious disease in older people is less effective than in younger adults, due to “immunosenescence”. There has…
read more here.
Keywords:
older adults;
cmv seropositive;
cd4 cells;
latent cmv ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0180691
Abstract: Cytomegalovirus (CMV) infection is associated with immune-suppression in immune-compromised hosts and old adults. We previously showed that ex vivo CMV restimulation of peripheral blood mononuclear cells (PBMC) of CMV-seropositive volunteers expanded CD4+CD27-CD28- regulatory T cells…
read more here.
Keywords:
cd27 cd28;
cmv seropositive;
cd27;
cd4 cd27 ... See more keywords